Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH)
Clinical trial NCT03203850 · TERMINATED
Trial details
- NCT number
- NCT03203850
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-11
- Primary completion
- 2023-04-17
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.